
    
      De novo Liver Transplant Recipients will be divided into two groups. Both groups will receive
      Prograf (Tacrolimus twice daily therapy), and at Month 1 (Week 4) after surgery, Prograf will
      be converted to Advagraf (modified release Tacrolimus, once daily) in one group, while
      Prograf therapy will be continued in other group.
    
  